MARILYN KING: Open Payments
NPI 1740286707 · SHOW LOW, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 16 payments from 14 companies in 2025. Trend: 2023 $836 · 2024 $899 · 2025 $447
Food & beverage: $364Long term medical supply or device loan: $83
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $83 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| JAZZ PHARMACEUTICALS INC. | 1 | $36 |
| PFIZER INC. | 2 | $35 |
| Celgene Corporation | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $29 |
| SOBI, INC | 1 | $27 |
| Caris MPI, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
Products named: KISQALI, OJJAARA, ZEPZELCA, POMALYST, Enhertu, Doptelet, MI CANCER SEEK, EPKINLY.
Industry payments across AZ — which companies pay providers there.
